Evvy is unlocking precision healthcare for women & people with vaginas.

Priyanka has always been passionate about leveraging data to improve outcomes for women.

She spent the past 4 years as Head of Product at pymetrics, where she focused on building algorithms to make hiring more fair, efficient, and transparent. She's excited about the opportunity to create new datasets that will help us improve diagnoses and treatments for women's health conditions that have gone under-researched for far too long.

Priyanka is also a spokesperson for the United Nations Foundation's Girl Up Campaign, Chair of the Acumen Fund's Junior Council, and on the Innovation Board for the XPrize Foundation. She received her B.S. from Stanford University, where she was a Mayfield Fellow and President of Stanford Women in Business.

Pita is a molecular biologist by training with a deep passion for driving the translation of scientific discoveries into technologies that can improve outcomes and empower women to live healthier lives. As an entrepreneur-scientist, her biotech start up experience spans across research, development and commercialization of novel diagnostics and digital health tools.

Prior to starting Evvy, Pita was a founding team member at Athelas where she lead the development of AI-based devices to monitor key biomarkers of inflammation for chronically ill patients.

Dr. Cohen is an OB-GYN research-scientist with over 28 years of studying the vaginal microbiome and its impact on reproductive health.

He led the first investigation to demonstrate an association between women with bacterial vaginosis and HIV, and since has been studying the vaginal microbiome in part to develop live biotherapeutic products to optimize the vaginal microbiome and improve reproductive health outcomes including the prevention of HIV acquisition.

The combined force led by Evvy to develop powerful datasets on the vaginal microbiome combined with the promise of new therapeutics creates the opportunity to significantly improve reproductive health outcomes for women in the US and around the world.

Dr. Stephen Klasko is a transformative leader and advocate for a revolution in our systems of health care and higher education.

As president of Thomas Jefferson University and CEO of Jefferson Health from 2013-2022, he led one of the nation’s fastest growing academic health institutions based on his vision of healthcare at any address He is an obstetrician who has advocated for how technology can transform women's healthcare and was the founding president of Spirit of Women, a groundbreaking grass roots women's health marketing campaign.

His track record of success has earned him over the past several years Modern Healthcare’s #2 in “100 Most Influential Individuals”; as #21 in Fast Company’s “100  Most Creative People in Business" ; Ernst & Young’s “Greater Philadelphia Entrepreneur of the  Year 2018”; and Becker's Hospital Review's “100 Great Leaders in Healthcare.”

Dr. Klasko is an internationally recognized advocate for transformation in health care and higher education. He is the author of 2020’s UnHealthcare: A Manifesto for Health Assurance, with General Catalyst's Hemant Taneja. In 2020, he was named a Distinguished Fellow of the World Economic Forum and co-chair of its Board of Stewards for the Forum's platform on the digital economy.  In 2022, his book "Feelin' Alright: How the Message in the Music Can Make Healthcare Healthier" channeled the song "Courage to Change" as a challenge to transform population health and health equity from philosophy to action.

Dr. Leah Millheiser, MD, FACOG, NCMP has devoted her career to researching and treating all aspects of female sexual health and menopause. In her role as the Director of the Female Sexual Medicine Program within the Division of Gynecology at Stanford University Medical Center, Dr. Millheiser takes care of women across the lifespan.

She has served as the principal investigator for many clinical trials in the area of women’s sexual health and has authored numerous publications on female sexual dysfunction and menopause for peer-reviewed journals and textbooks.

She is a frequent lecturer, both nationally and internationally, and serves as a women’s health expert for various television, online, and print media outlets.

As an OB-GYN, clinical researcher, and professor, Dr. Rahman provides evidence-based, de-stigmatizing information about women’s reproductive and sexual health. She is passionate about increasing awareness and greater cultural understanding of topics such as menstruation, sexual dysfunction, chronic pelvic pain, postpartum care, and menopause.

As a South Asian–American Muslim mother of three, she has a special interest in researching these areas within the Muslim population, which has been underserved both in the United States and abroad. Her dedication to women’s health care has taken her on medical missions around the globe, including working for the World Health Organization in Geneva, Switzerland, and have completed projects with a variety of international women’s organizations.

Dr. Rahman sits on the board of multiple organizations, including the Board of Directors of ISSWSH (International Society for the Study of Women's Sexual Health), the Board of Directors for HEART Women and Girls, and the Educational Committee for The North American Menopause Society. She also runs an Instagram channel, @gynogirl, where she answers questions and advocates for female health.

Professor Schiebinger is a leading international expert on gender in science & technology and has addressed the United Nations, the European Parliament, the Korean National Assembly, and numerous funding agencies on that topic.

Schiebinger received her Ph.D. from Harvard University, is an elected member of the American Academy of Arts and Sciences, and the recipient of numerous prizes and awards, including the prestigious Alexander von Humboldt Research Prize and Guggenheim Fellowship.

Gendered Innovations harnesses the creative power of sex, gender, and intersectional analysis to enhance excellence and reproducibility in science and technology: Sex and Gender Analysis Improves Science and Engineering Nature (2019).

Momo is an entrepreneur-scientist who is obsessed with building a healthier future in which chronic diseases and cancers are covered in history books, not TV commercials.

He has used his extensive scientific expertise and business acumen to lead the development of the core Viome technologies, and their application towards healthier humanity. These technologies are enabling the transformation of the current healthcare, which focuses on symptoms management, into a completely novel preventative and curative model, where individuals can take control of their own health.

Momo obtained his PhD in Chemistry from the University of Utah, and BS in Microbiology from the University of Texas at El Paso. He is also an adjunct professor at the New Mexico Tech University.

Laine’s north star has always been highlighting women in places they’ve been overlooked, from putting historic American women on money in augmented reality to finding new voices pushing the boundaries of film and media.

She’s a veteran of Google Creative Lab, Tribeca Film Festival, and the Stanford d.school.

When she’s not destigmatizing vaginal health, she’s playing video games and writing.

Dr. Kate McLean MD, MPH, FACOG is the Chief Medical Officer at Evvy.

Dr. McLean is a board-certified obstetrician-gynecologist, who received her undergraduate and doctoral degrees from the University of Chicago, then went on complete residency training and a Masters in Public Health at the University of Washington in Seattle. She has always been passionate about innovation in the reproductive health arena, and has previously held leadership positions at both non-profits working in low-resource settings abroad, as well as health tech start-ups in the US.

Dr. McLean is the immediate past Chair and current Legislative Chair for the Washington State Section of the American College of Obstetricians and Gynecologists, and has also successfully published a number of research studies in peer reviewed journals.

As the Chief Medical Officer at Evvy, she can’t wait to help bring the insights provided by the vaginal microbiome to the forefront of optimizing reproductive health.

Dr. Diana Currie is a faculty member of the Providence St. Peter Family Medicine Residency department in Olympia, WA, an affiliate of the University of Washington medical school. A passionate educator, she has been teaching medical students and residents for over 25 years. Dr. Currie attended Harvard Medical School where she received an Albert Schweitzer Fellowship in pediatric and adolescent gynecology with a focus on maternal and reproductive health disparities.

A board-certified OB-GYN, she values the trust her patients place in her hands, heart and judgement—whether it is to deliver their newborn baby, as they go to sleep on the operating room table, or in the clinic to keep them healthy. She provides women with information about their body which allows them to make informed decisions that can positively impact all areas of their life.

She is also well versed in Functional Medicine and believes that every individual deserves a personalized, whole person approach in achieving their optimum health.

Dr. Krapf is a board-certified OB-GYN and Vulvar and Vaginal Health Specialist.

She is the Associate Director for the Center for Vulvovaginal Disorders in Washington DC and an Associate Clinical Professor of Obstetrics and Gynecology at The George Washington University School of Medicine and Health Sciences. She is a Fellow of the International Society for the Study of Women’s Sexual Health (ISSWSH).  

Dr. Krapf is active in research and has published chapters and peer-reviewed articles on vulvodynia, vulvar lichen sclerosus, and vulvovaginitis.  

She is an Associate Editor for Sexual Medicine, as well as for the textbook Female Sexual Pain Disorders, 2nd Edition.  She is an author of When Sex Hurts: Understanding and Healing Pelvic Pain.

Dr. Kelle Moley is a career physician-scientist Obstetrician Gynecologist, who spent 30 years at Washington University in St. Louis where she was Director of the Center for Reproductive Health Sciences, co-Director of the Institute for Clinical and Translational Sciences, and had a success research laboratory studying reproductive health issues in animal models and humans, while also seeing infertility patients.  

She was elected to the National Academy of Medicine in 2014.  In 2018 she retired from academia to take the role of Chief Scientific Officer of March of Dimes, a nonprofit organization focused on finding causes of preterm birth and maternal mortality.  

From there she moved on to become the Deputy Director of a new division of Reproductive Health Technologies at the Bill and Melinda Gates Foundation. Over the last two-years she created a strategic research platform that focused on a holistic approach to sexual and reproductive health, by investment in biomedical technologies to change the care paradigm for women in low resource settings.

She is committed to women’s health is an advocate for women’s reproductive and sexual equity.

David Sable, MD, directs healthcare and life science investing for the Special Situations Funds and is portfolio manager of the Special Situations Life Sciences Fund and Life Sciences Innovation Venture Capital funds.

After graduating from the Wharton School and the University of Pennsylvania School of Medicine, he trained in obstetrics and gynecology at New York Hospital - Cornell Medical Center, and in reproductive endocrinology at the Brigham and Women's Hospital. He co-founded and served as director of the Institute for Reproductive Medicine and Science at Saint Barnabas Medical Center in New Jersey, was founder of Assisted Reproductive Medical Technologies, which was acquired by Saint Barnabas in 1999, and co-founder of Reprogenetics, acquired by Cooper Surgical in 2015. After leaving clinical medicine, Dr. Sable managed a proprietary healthcare portfolio at Deutsche Bank before joining the Special Situations Funds.

Dr. Sable is an adjunct in the department of biology at Columbia University, and teaches “Entrepreneurship in Biotechnology” at Columbia’s Graduate School of Arts and Sciences. He serves on the board of directors for Hamilton Thorne Ltd, AutoIvf, and Celmatix, is a clinical advisory board member for Conceivable and TMRW Life Sciences, and is a past director for the non-profit RESOLVE.

Sara Vaughn, MD is a double-board certified physician specializing in obstetrics, gynecology, reproductive endocrinology and infertility. Her clinical practice has been in Silicon Valley where she was the medical director of Spring Fertility in Sunnyvale and at Stanford University, where she established a teaching clinic in infertility for the resident physicians. Dr. Vaughn completed her education and medical training at multiple universities: Rice University, The University of Texas in Houston, Cedar Sinai Hospital in Los Angeles. Dr. Vaughn frequently consults for Silicon Valley venture funds and advises companies focused on reproductive science, fertility and women’s health. She is passionate about harnessing technology and innovation to develop high quality cost-effective health-care systems.